Work

Tolerability and outcomes with serial cycles of 28 days of venetoclax in newly diagnosed patients with AML.

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e18527

Authors: Jesse Sanchez, Michael Kenneth Jones, Katie Julian, Megan Phipps Connor, Rebecca Rezac, Kelsey Marciano, Katelyn Anttila, Connor Sohalski, Ayele Belachew, Matthew Angelos, Christine McMahon, Andrew Kent, Maria Amaya, Marc Schwartz, Jonathan Aaron Gutman, Daniel Aaron Pollyea

Institutions: University of Colorado Anschutz, University of Colorado Denver

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410807989

FWCI:

Cites:

Cited by:

Related to: 10